 | • レポートコード：20QY06-03636 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ペプチド治療剤のグローバル市場について種類別（注射、経口、その他）、用途別（癌、代謝障害、中枢神経系、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ペプチド治療剤市場の概要 ・世界の主要地域別ペプチド治療剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のペプチド治療剤市場規模2015-2026：種類別（注射、経口、その他） ・世界のペプチド治療剤市場規模2015-2026：用途別（癌、代謝障害、中枢神経系、その他） ・ペプチド治療剤の北米市場規模2015-2020 ・ペプチド治療剤のヨーロッパ市場規模2015-2020 ・ペプチド治療剤の中国市場規模2015-2020 ・ペプチド治療剤の日本市場規模2015-2020 ・ペプチド治療剤の東南アジア市場規模2015-2020 ・ペプチド治療剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi、Eli Lilly、Novo Nordisk、Takeda、Teva、Novartis、AstraZeneca、Ipsen、AbbVie、Allergan、Ferring、Merck、J & J、The Medicines） ・ペプチド治療剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ペプチド治療剤の市場動向・機会・課題 ・調査の結論 |
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.
North America is the largest consumption place, with a consumption market share nearly 60.9% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 21.3%, China and Japan are also an important sales region for the peptide therapeutics.
Market Analysis and Insights: Global Peptide Therapeutics Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Peptide Therapeutics market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Peptide Therapeutics industry.
Based on our recent survey, we have several different scenarios about the Peptide Therapeutics YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 31680 million in 2019. The market size of Peptide Therapeutics will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Peptide Therapeutics Scope and Market Size
The global Peptide Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peptide Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Peptide Therapeutics market is segmented into
Injection
Oral
Other
The proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.
Segment by Application, the Peptide Therapeutics market is segmented into
Cancer
Metabolic Disorders
Central Nervous System
Other
The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.
The Peptide Therapeutics market is analysed and market size information is provided by regions (countries). Segment by Application, the Peptide Therapeutics market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Peptide Therapeutics Market Share Analysis
Peptide Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Peptide Therapeutics business, the date to enter into the Peptide Therapeutics market, Peptide Therapeutics product introduction, recent developments, etc.
The major vendors covered:
Sanofi
Eli Lilly
Novo Nordisk
Takeda
Teva
Novartis
AstraZeneca
Ipsen
AbbVie
Allergan
Ferring
Merck
J & J
The Medicines
1 Peptide Therapeutics Market Overview
1.1 Peptide Therapeutics Product Scope
1.2 Peptide Therapeutics Segment by Type
1.2.1 Global Peptide Therapeutics Sales by Type (2020-2026)
1.2.2 Injection
1.2.3 Oral
1.2.4 Other
1.3 Peptide Therapeutics Segment by Application
1.3.1 Global Peptide Therapeutics Sales Comparison by Application (2020-2026)
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Peptide Therapeutics Market Estimates and Forecasts (2015-2026)
1.4.1 Global Peptide Therapeutics Sales Growth Rate (2015-2026)
1.4.2 Global Peptide Therapeutics Revenue and Growth Rate (2015-2026)
1.4.3 Global Peptide Therapeutics Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Peptide Therapeutics Industry Impact
1.5.1 How the Covid-19 is Affecting the Peptide Therapeutics Industry
1.5.1.1 Peptide Therapeutics Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Peptide Therapeutics Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Peptide Therapeutics Players to Combat Covid-19 Impact
2 Peptide Therapeutics Estimate and Forecast by Region
2.1 Global Peptide Therapeutics Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Peptide Therapeutics Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Peptide Therapeutics Sales Market Share by Region (2015-2020)
2.2.2 Global Peptide Therapeutics Revenue Market Share by Region (2015-2020)
2.3 Global Peptide Therapeutics Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Peptide Therapeutics Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Peptide Therapeutics Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Peptide Therapeutics Estimates and Projections (2015-2026)
2.4.2 Europe Peptide Therapeutics Estimates and Projections (2015-2026)
2.4.3 China Peptide Therapeutics Estimates and Projections (2015-2026)
2.4.4 Japan Peptide Therapeutics Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Peptide Therapeutics Estimates and Projections (2015-2026)
2.4.6 India Peptide Therapeutics Estimates and Projections (2015-2026)
3 Global Peptide Therapeutics Competition Landscape by Players
3.1 Global Top Peptide Therapeutics Players by Sales (2015-2020)
3.2 Global Top Peptide Therapeutics Players by Revenue (2015-2020)
3.3 Global Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Therapeutics as of 2019)
3.4 Global Peptide Therapeutics Average Price by Company (2015-2020)
3.5 Manufacturers Peptide Therapeutics Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Peptide Therapeutics Players (Opinion Leaders)
4 Global Peptide Therapeutics Market Size by Type
4.1 Global Peptide Therapeutics Historic Market Review by Type (2015-2020)
4.1.1 Global Peptide Therapeutics Sales Market Share by Type (2015-2020)
4.1.2 Global Peptide Therapeutics Revenue Market Share by Type (2015-2020)
4.1.3 Global Peptide Therapeutics Price by Type (2014-2020)
4.2 Global Peptide Therapeutics Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Peptide Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Peptide Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Global Peptide Therapeutics Price Forecast by Type (2021-2026)
5 Global Peptide Therapeutics Market Size by Application
5.1 Global Peptide Therapeutics Historic Market Review by Application (2015-2020)
5.1.1 Global Peptide Therapeutics Sales Market Share by Application (2015-2020)
5.1.2 Global Peptide Therapeutics Revenue Market Share by Application (2015-2020)
5.1.3 Global Peptide Therapeutics Price by Application (2015-2020)
5.2 Global Peptide Therapeutics Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Peptide Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Peptide Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Peptide Therapeutics Price Forecast by Application (2021-2026)
3 North America Peptide Therapeutics Market Facts & Figures
3.2 North America Peptide Therapeutics Sales Market Share by Company (2015-2020)
3.3 North America Peptide Therapeutics Sales Market Share by Type (2015-2020)
3.4 North America Peptide Therapeutics Sales Market Share by Application (2015-2020)
4 Europe Peptide Therapeutics Market Facts & Figures
4.2 Europe Peptide Therapeutics Sales Market Share by Company (2015-2020)
4.3 Europe Peptide Therapeutics Sales Market Share by Type (2015-2020)
4.4 Europe Peptide Therapeutics Sales Market Share by Application (2015-2020)
5 China Peptide Therapeutics Market Facts & Figures
5.2 China Peptide Therapeutics Sales Market Share by Company (2015-2020)
5.3 China Peptide Therapeutics Sales Market Share by Type (2015-2020)
5.4 China Peptide Therapeutics Sales Market Share by Application (2015-2020)
6 Japan Peptide Therapeutics Market Facts & Figures
6.2 Japan Peptide Therapeutics Sales Market Share by Company (2015-2020)
6.3 Japan Peptide Therapeutics Sales Market Share by Type (2015-2020)
6.4 Japan Peptide Therapeutics Sales Market Share by Application (2015-2020)
7 Southeast Asia Peptide Therapeutics Market Facts & Figures
7.2 Southeast Asia Peptide Therapeutics Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Peptide Therapeutics Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Peptide Therapeutics Sales Market Share by Application (2015-2020)
8 India Peptide Therapeutics Market Facts & Figures
8.2 India Peptide Therapeutics Sales Market Share by Company (2015-2020)
8.3 India Peptide Therapeutics Sales Market Share by Type (2015-2020)
8.4 India Peptide Therapeutics Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Peptide Therapeutics Business
12.1 Sanofi
12.1.1 Sanofi Peptide Therapeutics Corporation Information
12.1.2 Sanofi Peptide Therapeutics Business Overview and Total Revenue
12.1.3 Sanofi Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Peptide Therapeutics Products Offered
12.1.5 Sanofi Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Peptide Therapeutics Corporation Information
12.2.2 Eli Lilly Peptide Therapeutics Business Overview and Total Revenue
12.2.3 Eli Lilly Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Eli Lilly Peptide Therapeutics Products Offered
12.2.5 Eli Lilly Recent Development
12.3 Novo Nordisk
12.3.1 Novo Nordisk Peptide Therapeutics Corporation Information
12.3.2 Novo Nordisk Peptide Therapeutics Business Overview and Total Revenue
12.3.3 Novo Nordisk Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novo Nordisk Peptide Therapeutics Products Offered
12.3.5 Novo Nordisk Recent Development
12.4 Takeda
12.4.1 Takeda Peptide Therapeutics Corporation Information
12.4.2 Takeda Peptide Therapeutics Business Overview and Total Revenue
12.4.3 Takeda Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Takeda Peptide Therapeutics Products Offered
12.4.5 Takeda Recent Development
12.5 Teva
12.5.1 Teva Peptide Therapeutics Corporation Information
12.5.2 Teva Peptide Therapeutics Business Overview and Total Revenue
12.5.3 Teva Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Teva Peptide Therapeutics Products Offered
12.5.5 Teva Recent Development
12.6 Novartis
12.6.1 Novartis Peptide Therapeutics Corporation Information
12.6.2 Novartis Peptide Therapeutics Business Overview and Total Revenue
12.6.3 Novartis Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Novartis Peptide Therapeutics Products Offered
12.6.5 Novartis Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Peptide Therapeutics Corporation Information
12.7.2 AstraZeneca Peptide Therapeutics Business Overview and Total Revenue
12.7.3 AstraZeneca Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.7.4 AstraZeneca Peptide Therapeutics Products Offered
12.7.5 AstraZeneca Recent Development
12.8 Ipsen
12.8.1 Ipsen Peptide Therapeutics Corporation Information
12.8.2 Ipsen Peptide Therapeutics Business Overview and Total Revenue
12.8.3 Ipsen Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Ipsen Peptide Therapeutics Products Offered
12.8.5 Ipsen Recent Development
12.9 AbbVie
12.9.1 AbbVie Peptide Therapeutics Corporation Information
12.9.2 AbbVie Peptide Therapeutics Business Overview and Total Revenue
12.9.3 AbbVie Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.9.4 AbbVie Peptide Therapeutics Products Offered
12.9.5 AbbVie Recent Development
12.10 Allergan
12.10.1 Allergan Peptide Therapeutics Corporation Information
12.10.2 Allergan Peptide Therapeutics Business Overview and Total Revenue
12.10.3 Allergan Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Allergan Peptide Therapeutics Products Offered
12.10.5 Allergan Recent Development
12.11 Ferring
12.11.1 Ferring Peptide Therapeutics Corporation Information
12.11.2 Ferring Peptide Therapeutics Business Overview and Total Revenue
12.11.3 Ferring Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Ferring Peptide Therapeutics Products Offered
12.11.5 Ferring Recent Development
12.12 Merck
12.12.1 Merck Peptide Therapeutics Corporation Information
12.12.2 Merck Peptide Therapeutics Business Overview and Total Revenue
12.12.3 Merck Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Merck Peptide Therapeutics Products Offered
12.12.5 Merck Recent Development
12.13 J & J
12.13.1 J & J Peptide Therapeutics Corporation Information
12.13.2 J & J Peptide Therapeutics Business Overview and Total Revenue
12.13.3 J & J Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.13.4 J & J Peptide Therapeutics Products Offered
12.13.5 J & J Recent Development
12.14 The Medicines
12.14.1 The Medicines Peptide Therapeutics Corporation Information
12.14.2 The Medicines Peptide Therapeutics Business Overview and Total Revenue
12.14.3 The Medicines Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.14.4 The Medicines Peptide Therapeutics Products Offered
12.14.5 The Medicines Recent Development
13 Peptide Therapeutics Manufacturing Cost Analysis
13.1 Peptide Therapeutics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Peptide Therapeutics
13.4 Peptide Therapeutics Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Peptide Therapeutics Distributors List
14.3 Peptide Therapeutics Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Peptide Therapeutics Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Peptide Therapeutics Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Peptide Therapeutics Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Peptide Therapeutics Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Peptide Therapeutics Players to Combat Covid-19 Impact
Table 8. Global Market Peptide Therapeutics Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Peptide Therapeutics Sales (K Units) by Region (2015-2020)
Table 10. Global Peptide Therapeutics Sales Market Share by Region (2015-2020)
Table 11. Global Peptide Therapeutics Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Peptide Therapeutics Revenue Share by Region (2015-2020)
Table 13. Global Peptide Therapeutics Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Peptide Therapeutics Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Peptide Therapeutics Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Peptide Therapeutics Revenue Share Forecast by Region (2021-2026)
Table 17. Global Peptide Therapeutics (K Units) of Key Companies (2015-2020)
Table 18. Global Peptide Therapeutics Sales Share by Company (2015-2020)
Table 19. Global Peptide Therapeutics Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Peptide Therapeutics Revenue Share by Company (2015-2020)
Table 21. Global Peptide Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Therapeutics as of 2019)
Table 22. Global Peptide Therapeutics Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Peptide Therapeutics Manufacturing Sites and Area Served
Table 24. Manufacturers Peptide Therapeutics Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Peptide Therapeutics Players
Table 27. Global Peptide Therapeutics Sales (K Units) by Type (2015-2020)
Table 28. Global Peptide Therapeutics Sales Share by Type (2015-2020)
Table 29. Global Peptide Therapeutics Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Peptide Therapeutics Price (K Units) by Type (2015-2020)
Table 31. Global Peptide Therapeutics Sales Share by Type (2021-2026)
Table 32. Global Peptide Therapeutics Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Peptide Therapeutics Revenue Share by Type (2021-2026)
Table 34. Global Peptide Therapeutics Price (K Units) by Type (2021-2026)
Table 35. Global Peptide Therapeutics Sales (K Units) by Application (2015-2020)
Table 36. Global Peptide Therapeutics Sales Share by Application (2015-2020)
Table 37. Global Peptide Therapeutics Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Peptide Therapeutics Price (K Units) by Application (2015-2020)
Table 39. Global Peptide Therapeutics Sales (K Units) by Application (2021-2026)
Table 40. Global Peptide Therapeutics Sales Share by Application (2021-2026)
Table 41. Global Peptide Therapeutics Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Peptide Therapeutics Revenue Share by Application (2021-2026)
Table 43. Global Peptide Therapeutics Price (K Units) by Application (2021-2026)
Table 44. United States Peptide Therapeutics Sales (K Units) by Company (2015-2020)
Table 45. United States Peptide Therapeutics Sales Market Share by Company (2015-2020)
Table 46. United States Peptide Therapeutics Sales (K Units) by Type (2015-2020)
Table 47. United States Peptide Therapeutics Sales Market Share by Type (2015-2020)
Table 48. United States Peptide Therapeutics Sales (K Units) by Application (2015-2020)
Table 49. United States Peptide Therapeutics Sales Market Share by Application (2015-2020)
Table 50. Europe Peptide Therapeutics Sales (K Units) by Company (2015-2020)
Table 51. Europe Peptide Therapeutics Sales Market Share by Company (2015-2020)
Table 52. Europe Peptide Therapeutics Sales (K Units) by Type (2015-2020)
Table 53. Europe Peptide Therapeutics Sales Market Share by Type (2015-2020)
Table 54. Europe Peptide Therapeutics Sales (K Units) by Application (2015-2020)
Table 55. Europe Peptide Therapeutics Sales Market Share by Type (2015-2020)
Table 56. China Peptide Therapeutics Sales (K Units) by Company (2015-2020)
Table 57. China Peptide Therapeutics Sales Market Share by Company (2015-2020)
Table 58. China Peptide Therapeutics Sales (K Units) by Type (2015-2020)
Table 59. China Peptide Therapeutics Sales Market Share by Type (2015-2020)
Table 60. China Peptide Therapeutics Sales (K Units) by Application (2015-2020)
Table 61. China Peptide Therapeutics Sales Market Share by Application (2015-2020)
Table 62. Japan Peptide Therapeutics Sales (K Units) by Company (2015-2020)
Table 63. Japan Peptide Therapeutics Sales Market Share by Company (2015-2020)
Table 64. Japan Peptide Therapeutics Sales (K Units) by Type (2015-2020)
Table 65. Japan Peptide Therapeutics Sales Market Share by Type (2015-2020)
Table 66. Japan Peptide Therapeutics Sales (K Units) by Application (2015-2020)
Table 67. Japan Peptide Therapeutics Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Peptide Therapeutics Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Peptide Therapeutics Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Peptide Therapeutics Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Peptide Therapeutics Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Peptide Therapeutics Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Peptide Therapeutics Sales Market Share by Application (2015-2020)
Table 74. India Peptide Therapeutics Sales (K Units) by Company (2015-2020)
Table 75. India Peptide Therapeutics Sales Market Share by Company (2015-2020)
Table 76. India Peptide Therapeutics Sales (K Units) by Type (2015-2020)
Table 77. India Peptide Therapeutics Sales Market Share by Type (2015-2020)
Table 78. India Peptide Therapeutics Sales (K Units) by Application (2015-2020)
Table 79. India Peptide Therapeutics Sales Market Share by Application (2015-2020)
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Sanofi Peptide Therapeutics Product
Table 84. Sanofi Recent Development
Table 85. Eli Lilly Corporation Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Eli Lilly Peptide Therapeutics Product
Table 89. Eli Lilly Recent Development
Table 90. Novo Nordisk Corporation Information
Table 91. Novo Nordisk Description and Business Overview
Table 92. Novo Nordisk Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Novo Nordisk Peptide Therapeutics Product
Table 94. Novo Nordisk Recent Development
Table 95. Takeda Corporation Information
Table 96. Takeda Description and Business Overview
Table 97. Takeda Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Takeda Peptide Therapeutics Product
Table 99. Takeda Recent Development
Table 100. Teva Corporation Information
Table 101. Teva Description and Business Overview
Table 102. Teva Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Teva Peptide Therapeutics Product
Table 104. Teva Recent Development
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Novartis Peptide Therapeutics Product
Table 109. Novartis Recent Development
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. AstraZeneca Peptide Therapeutics Product
Table 114. AstraZeneca Recent Development
Table 115. Ipsen Corporation Information
Table 116. Ipsen Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Ipsen Description and Business Overview
Table 118. Ipsen Peptide Therapeutics Product
Table 119. Ipsen Recent Development
Table 120. AbbVie Corporation Information
Table 121. AbbVie Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. AbbVie Description and Business Overview
Table 123. AbbVie Peptide Therapeutics Product
Table 124. AbbVie Recent Development
Table 125. Allergan Corporation Information
Table 126. Allergan Description and Business Overview
Table 127. Allergan Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Allergan Peptide Therapeutics Product
Table 129. Allergan Recent Development
Table 130. Ferring Corporation Information
Table 131. Ferring Description and Business Overview
Table 132. Ferring Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Ferring Peptide Therapeutics Product
Table 134. Ferring Recent Development
Table 135. Merck Corporation Information
Table 136. Merck Description and Business Overview
Table 137. Merck Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Merck Peptide Therapeutics Product
Table 139. Merck Recent Development
Table 140. J & J Corporation Information
Table 141. J & J Description and Business Overview
Table 142. J & J Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. J & J Peptide Therapeutics Product
Table 144. J & J Recent Development
Table . The Medicines Corporation Information
Table . The Medicines Description and Business Overview
Table . The Medicines Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . The Medicines Peptide Therapeutics Product
Table . The Medicines Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Peptide Therapeutics Distributors List
Table 153. Peptide Therapeutics Customers List
Table 154. Market Key Trends
Table 155. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 156. Key Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Therapeutics Product Picture
Figure 2. Global Peptide Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Peptide Therapeutics Market Share by Application in 2020 & 2026
Figure 6. Cancer Examples
Figure 7. Metabolic Disorders Examples
Figure 8. Central Nervous System Examples
Figure 9. Other Examples
Figure 10. Global Peptide Therapeutics Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Peptide Therapeutics Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Peptide Therapeutics Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Peptide Therapeutics Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Peptide Therapeutics Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Peptide Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Peptide Therapeutics Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Peptide Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Peptide Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Peptide Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Peptide Therapeutics Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Peptide Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Peptide Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Peptide Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Peptide Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Peptide Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Peptide Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Peptide Therapeutics Players Market Share by Revenue in Peptide Therapeutics 2015 & 2019
Figure 28. Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Peptide Therapeutics Revenue Share by Type (2015-2020)
Figure 30. Global Peptide Therapeutics Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Peptide Therapeutics Revenue Share by Application (2015-2020)
Figure 32. Global Peptide Therapeutics Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Peptide Therapeutics Sales Market Share by Type in 2019
Figure 34. United States Peptide Therapeutics Sales Market Share by Type in 2019
Figure 35. Europe Peptide Therapeutics Sales Market Share by Company in 2019
Figure 36. Europe Peptide Therapeutics Sales Market Share by Type in 2019
Figure 37. Europe Peptide Therapeutics Sales Market Share by Application in 2019
Figure 38. China Peptide Therapeutics Sales Market Share by Company in 2019
Figure 39. China Peptide Therapeutics Sales Market Share by Type in 2019
Figure 40. China Peptide Therapeutics Sales Market Share by Application in 2019
Figure 41. Japan Peptide Therapeutics Sales Market Share by Company in 2019
Figure 42. Japan Peptide Therapeutics Sales Market Share by Type in 2019
Figure 43. Japan Peptide Therapeutics Sales Market Share by Application in 2019
Figure 44. Southeast Asia Peptide Therapeutics Sales Market Share by Company in 2019
Figure 45. Southeast Asia Peptide Therapeutics Sales Market Share by Type in 2019
Figure 46. Southeast Asia Peptide Therapeutics Sales Market Share by Application in 2019
Figure 47. India Peptide Therapeutics Sales Market Share by Company in 2019
Figure 48. India Peptide Therapeutics Sales Market Share by Type in 2019
Figure 49. India Peptide Therapeutics Sales Market Share by Application in 2019
Figure 50. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Ipsen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Ferring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. J & J Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. The Medicines Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Key Raw Materials Price Trend
Figure 65. Manufacturing Cost Structure of Peptide Therapeutics
Figure 66. Manufacturing Process Analysis of Peptide Therapeutics
Figure 67. Peptide Therapeutics Industrial Chain Analysis
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. Porter's Five Forces Analysis
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
グルカゴン様ペプチド-2（GLP-2）アゴニストの世界市場レポート2020 A recently published report by QY Research titled Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistica…- ペプチド核酸の世界市場レポート2020 Market Analysis and Insights: Global Peptide Nucleic Acid Market The global Peptide Nucleic Acid market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Peptide Nucleic Acid Scope and Market Size The global Pepti…
- 癌ペプチドワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Peptide Cancer Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accu…
- マリンボーンコラーゲンペプチドパウダーの世界市場レポート2020 Market Analysis and Insights: Global Marine Bone Collagen Peptide Powder Market The global Marine Bone Collagen Peptide Powder market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Marine Bone Collagen Peptide …
- グリコシル化ヘモグロビンCペプチドの世界市場レポート2020 Market Analysis and Insights: Global Glycosylated Hemoglobin C-peptide Market The global Glycosylated Hemoglobin C-peptide market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Glycosylated Hemoglobin C-peptide…